| 1 | needs of its clients | | | | | | | 3 | 0.83% |
| 2 | maxwin technologies is well | | | | | | | 3 | 0.83% |
| 3 | services needs of its | | | | | | | 3 | 0.83% |
| 4 | its clients adhering to | | | | | | | 2 | 0.55% |
| 5 | of its clients adhering | | | | | | | 2 | 0.55% |
| 6 | – based on natural | | | | | | | 2 | 0.55% |
| 7 | to meet the basicdetailed | | | | | | | 2 | 0.55% |
| 8 | equipped to meet the | | | | | | | 2 | 0.55% |
| 9 | well equipped to meet | | | | | | | 2 | 0.55% |
| 10 | lle atfd and atf | | | | | | | 2 | 0.55% |
| 11 | is well equipped to | | | | | | | 2 | 0.55% |
| 12 | clients adhering to processsafety | | | | | | | 2 | 0.55% |
| 13 | basic engineering group consists | | | | | | | 1 | 0.28% |
| 14 | used for 34 given | | | | | | | 1 | 0.28% |
| 15 | well capable of handling | | | | | | | 1 | 0.28% |
| 16 | capable of handling engineering | | | | | | | 1 | 0.28% |
| 17 | products etc the basic | | | | | | | 1 | 0.28% |
| 18 | consulting services to its | | | | | | | 1 | 0.28% |
| 19 | services to its clients | | | | | | | 1 | 0.28% |
| 20 | to its clients turnkey | | | | | | | 1 | 0.28% |
| 21 | its clients turnkey soluions | | | | | | | 1 | 0.28% |
| 22 | designingfabrication of a single | | | | | | | 1 | 0.28% |
| 23 | of a single solvent | | | | | | | 1 | 0.28% |
| 24 | a single solvent recovery | | | | | | | 1 | 0.28% |
| 25 | single solvent recovery system | | | | | | | 1 | 0.28% |
| 26 | solvent recovery system which | | | | | | | 1 | 0.28% |
| 27 | recovery system which can | | | | | | | 1 | 0.28% |
| 28 | system which can be | | | | | | | 1 | 0.28% |
| 29 | for 34 given solvent | | | | | | | 1 | 0.28% |
| 30 | technologies is well capable | | | | | | | 1 | 0.28% |
| 31 | 34 given solvent mixtures | | | | | | | 1 | 0.28% |
| 32 | given solvent mixtures pilot | | | | | | | 1 | 0.28% |
| 33 | solvent mixtures pilot trials | | | | | | | 1 | 0.28% |
| 34 | oncology products etc the | | | | | | | 1 | 0.28% |
| 35 | for oncology products etc | | | | | | | 1 | 0.28% |
| 36 | api’s for oncology products | | | | | | | 1 | 0.28% |
| 37 | mixtures pilot trials of | | | | | | | 1 | 0.28% |
| 38 | atfd and atf to | | | | | | | 1 | 0.28% |
| 39 | prove the design concept | | | | | | | 1 | 0.28% |
| 40 | the design concept before | | | | | | | 1 | 0.28% |